Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tagra Biotechnologies is a specialized biotech company focused on the development and manufacture of advanced microencapsulation technologies for the cosmetic, personal care, and pharmaceutical sectors. Established in 1998 and based in Israel, the company is renowned for its proprietary Release on Demand (R.O.D.) technology, which enables the stabilization of sensitive active ingredients and prevents premature degradation. Their innovative delivery systems allow for the encapsulation of vitamins, UV filters, and pigments, ensuring they are released only upon application through mechanical pressure. Tagra's solutions address formulation challenges such as ingredient cross-reactivity, color shifting, and unpleasant odors. The company serves a global clientele, including many of the world's leading beauty and healthcare brands. By providing high-performance delivery systems, Tagra enhances the efficacy and shelf-life of topical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tagra Biotechnologies.